Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 2,750 shares at $50.00 ($138K) on 2021-08-25, disclosed to the SEC on 2021-08-26.
Open-market sale of $138k VIR by EVP, Research & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |